Dose-dependent sustained release of dexamethasone in inner ear cochlear fluids using a novel local delivery approach

Audiology and Neurotology

Volumn 14, Issue 6, 2009, Pages 393-401

  Wang, Xiaobo ^a   Dellamary, Luis ^a   Fernandez, Rayne ^a   Harrop, Anne ^a   Keithley, Elizabeth M ^b   Harris, Jeffrey P ^b   Ye, Qiang ^a   Lichter, Jay ^a   Lebel, Carl ^a   Piu, Fabrice ^a  

^a Otonomy Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dexamethasone; Hydrogel; Inner ear; Sustained release

Indexed keywords

ANALYSIS OF VARIANCE; ANIMALS; COCHLEA; DELAYED-ACTION PREPARATIONS; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG CARRIERS; ELECTROPHYSIOLOGY; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; GUINEA PIGS; HEARING; HEARING TESTS; PERILYMPH; POLOXAMER; TYMPANIC MEMBRANE;

EID: 73349085573     PISSN: 14203030     EISSN: 14219700     Source Type: Journal    
DOI: 10.1159/000241896     Document Type: Article

References (28)

1. Araujo MF, Oliveira CA, Bahmad FM Jr: Intratympanic dexamethasone injections as a treatment for severe, disabling tinnitus: Does it work? Arch Otolaryngol Head Neck Surg 2005; 131: 113-117.
2. Battaglia A, Burchette R, Cueva R: Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2008; 29: 453-460.
3. Bird PA, Begg EJ, Zhang M, Keast AT, Murray DP, Balkany TJ: Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol 2007; 28: 1124-1130.
4. Chandrasekhar SS: Intratympanic dexamethasone for sudden sensorineural hearing loss: Clinical and laboratory evaluation. Otol Neurotol 2001; 22: 18-23.
5. Chen G, Hou SX, Liu J: In vivo distribution and pharmacokinetics of dexamethasone-loaded nanoparticle after intratympanic application in guinea pigs (in Chinese). Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2007; 42: 533-534.
6. Chen G, Hou SX, Liu J, Luan JG, Zhang Y: In vivo distribution and pharmacokinetics of dexamethasone sodium phosphate thermosensitive in situ gel following intratympanic injection (in Chinese). Sichuan Da Xue Xue Bao Yi Xue Ban 2006; 37: 456-459.
7. Sichuan Da Xue Xue Bao Yi Xue Ban 2006; 37: 456-459. Dumortier G, Grossiord JL, Agnely F, Chaumeil JC: A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 2006; 23: 2709-2728.
8. Endo T, Nakagawa T, Kita T, Iguchi F, Kim TS, Tamura T, Iwai K, Tabata Y, Ito J: Novel strategy for treatment of inner ears using a biodegradable gel. Laryngoscope 2005; 115: 2016-2020.
9. Feng HY, Sun JJ, Jiang P: Effect of poloxamer 407 on the middle ear and inner ear after regional perfusion in guinea pigs (in Chinese). Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2007; 42: 443-446.
10. Garduno-Anaya MA, Couthino De Toledo H, Hinojosa-Gonzalez R, Pane-Pianese C, Rios-Castaneda LC: Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: A two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg 2005; 133: 285-294.
11. Inaoka T, Nakagawa T, Kikkawa YS, Tabata Y, Ono K, Yoshida M, Tsubouchi H, Ido A, Ito J: Local application of hepatocyte growth factor using gelatin hydrogels attenuates noise-induced hearing loss in guinea pigs. Acta Otolaryngol 2009; 129: 453-457.
12. Ito J, Endo T, Nakagawa T, Kita T, Kim TS, Iguchi F: A new method for drug application to the inner ear. ORL J Otorhinolaryngol Relat Spec 2005; 67: 272-275.
13. Kelly RM, Meyer JD, Matsuura JE, Shefter E, Hart MJ, Malone DJ, Manning MC: In vitro release kinetics of gentamycin from a sodium hyaluronate gel delivery system suitable for the treatment of peripheral vestibular disease. Drug Dev Ind Pharm 1999; 25: 15-20.
14. Kitahara T, Kubo T, Okumura S, Kitahara M: Effects of endolymphatic sac drainage with steroids for intractable Meniere's disease: A long-term follow-up and randomized controlled study. Laryngoscope 2008; 118: 854-861.
15. Kopke RD, Hoffer ME, Wester D, O'Leary MJ, Jackson RL: Targeted topical steroid therapy in sudden sensorineural hearing loss. Otol Neurotol 2001; 22: 475-479.
16. Paulson DP, Abuzeid W, Jiang H, Oe T, O'Malley BW, Li D: A novel controlled local drug delivery system for inner ear disease. Laryngoscope 2008; 118: 706-711.
17. Plontke SK, Lowenheim H, Mertens J, Engel C, Meisner C, Weidner A, Zimmermann R, Preyer S, Koitschev A, Zenner HP: Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2009; 119: 359-369.
18. Plontke SK, Mikulec AA, Salt AN: Rapid clearance of methylprednisolone after intratympanic application in humans. Comment on: Bird PA, Begg EJ, Zhang M, et al. Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol 2007; 28: 1124-1130. Otol Neurotol 2008; 29: 732-733, author reply 733.
19. Plontke SK, Salt AN: Simulation of application strategies for local drug delivery to the inner ear. ORL J Otorhinolaryngol Relat Spec 2006; 68: 386-392.
20. Plontke SK, Siedow N, Wegener R, Zenner HP, Salt AN: Cochlear pharmacokinetics with local inner ear drug delivery using a threedimensional finite-element computer model. Audiol Neurootol 2007; 12: 37-48.
21. Salt AN: Pharmacokinetics of drug entry into cochlear fluids. Volta Rev 2006; 105: 277-298.
22. Salt AN, Plontke SK: Local inner-ear drug delivery and pharmacokinetics. Drug Discov Today 2005; 10: 1299-1306.
23. Schmolka IR: Bwc surfactants in gel cosmetics. Cosm Toil 1977; 92: 77-79.
24. Silverstein H, Farrugia M, Van Ess M: Dexamethasone inner ear perfusion for subclinical endolymphatic hydrops. Ear Nose Throat J 2009; 88: 778-785.
25. Silverstein H, Isaacson JE, Olds MJ, Rowan PT, Rosenberg S: Dexamethasone inner ear perfusion for the treatment of Meniere's disease: A prospective, randomized, double-blind, crossover trial. Am J Otol 1998; 19: 196-201.
26. Singh-Joy SD, McLain VC: Safety assessment of poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, poloxamer 105 benzoate, and poloxamer 182 dibenzoate as used in cosmetics. Int J Toxicol 2008; 27(suppl 2):93-128.
27. Tamura T, Kita T, Nakagawa T, Endo T, Kim TS, Ishihara T, Mizushima Y, Higaki M, Ito J: Drug delivery to the cochlea using PLGA nanoparticles. Laryngoscope 2005; 115: 2000-2005.
28. Xenellis J, Papadimitriou N, Nikolopoulos T, Maragoudakis P, Segas J, Tzagaroulakis A, Ferekidis E: Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: A control study. Otolaryngol Head Neck Surg 2006; 134: 940-945.